According to BioNTech's latest financial reports the company has a price-to-book ratio of 1.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 2.02 | -56.49% |
2021-12-31 | 4.64 | -60.1% |
2020-12-31 | 11.6 | -16.3% |
2019-12-31 | 13.9 | INF% |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | 1.15 | -6.00% | ๐บ๐ธ USA |